Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Management of MF in 2020: Rux Failure, Fedratinib Approval, Data on Navitoclax, Luspatercept, Pacritinib, and Momelotinib
Login to view comments.
Click here to Login
Malignant Hematology